SUDEEP PHARMA
|
SUDEEP PHARMA Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 15.31 | 14.27 | 945.26 | 442.31 | 356.01 |
| CEPS(Rs) | 16.74 | 15.36 | 14.65 | 7.23 | 5.63 |
| DPS(Rs) | 1.50 | - | - | - | - |
| Book NAV/Share(Rs) | 78.21 | 50.48 | 2,526.86 | 1,584.71 | 1,159.15 |
| Tax Rate(%) | 23.58 | 24.13 | 23.81 | 27.52 | 26.87 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 34.05 | 36.47 | 39.73 | 21.03 | 19.67 |
| EBIT Margin(%) | 36.16 | 36.22 | 39.09 | 21.40 | 20.50 |
| Pre Tax Margin(%) | 34.86 | 34.91 | 38.06 | 20.05 | 20.00 |
| PAT Margin (%) | 26.64 | 26.48 | 29.00 | 14.54 | 14.63 |
| Cash Profit Margin (%) | 28.90 | 28.51 | 30.96 | 16.38 | 15.95 |
| Performance Ratios | |||||
| ROA(%) | 18.43 | 22.55 | 28.54 | 16.33 | 18.03 |
| ROE(%) | 25.37 | 32.76 | 45.98 | 32.24 | 36.15 |
| ROCE(%) | 28.50 | 35.83 | 48.76 | 33.22 | 35.85 |
| Asset Turnover(x) | 0.69 | 0.85 | 0.98 | 1.12 | 1.23 |
| Sales/Fixed Asset(x) | 2.20 | 2.54 | 2.53 | 2.65 | 2.86 |
| Working Capital/Sales(x) | 1.55 | 2.10 | 3.32 | 7.24 | 6.91 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.45 | 0.39 | 0.40 | 0.38 | 0.35 |
| Receivable days | 115.16 | 114.95 | 94.68 | 85.40 | 86.25 |
| Inventory Days | 96.15 | 68.03 | 54.67 | 45.77 | 28.73 |
| Payable days | 106.08 | 133.44 | 100.79 | 68.31 | 63.28 |
| Valuation Parameters | |||||
| PER(x) | 38.70 | - | - | - | - |
| PCE(x) | 35.38 | - | - | - | - |
| Price/Book(x) | 7.57 | - | - | - | - |
| Yield(%) | 0.25 | - | - | - | - |
| EV/Net Sales(x) | 10.47 | 0.19 | 0.14 | 0.17 | 0.19 |
| EV/Core EBITDA(x) | 26.75 | 0.48 | 0.33 | 0.74 | 0.85 |
| EV/EBIT(x) | 28.42 | 0.50 | 0.35 | 0.80 | 0.90 |
| EV/CE(x) | 6.52 | 0.15 | 0.14 | 0.24 | 0.26 |
| M Cap / Sales | 10.42 | - | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 27.94 | 9.30 | 7.12 | 24.99 | 59.46 |
| Core EBITDA Growth(%) | 25.48 | 6.24 | 89.17 | 33.18 | 57.50 |
| EBIT Growth(%) | 24.68 | 5.68 | 95.67 | 30.49 | 59.86 |
| PAT Growth(%) | 25.63 | 4.16 | 113.71 | 24.23 | 50.46 |
| EPS Growth(%) | 7.28 | -98.49 | 113.71 | 24.24 | 50.46 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.17 | 0.27 | 0.21 | 0.37 | 0.51 |
| Current Ratio(x) | 3.09 | 2.43 | 2.01 | 1.35 | 1.34 |
| Quick Ratio(x) | 2.02 | 1.69 | 1.53 | 0.93 | 1.09 |
| Interest Cover(x) | 27.82 | 27.49 | 37.92 | 15.87 | 40.89 |
| Total Debt/Mcap(x) | 0.02 | - | - | - | - |
Compare Financial Ratios of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹12,432.5 Cr | -0.4% | 27.2% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -0.4% |
27.2% |
|
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses
